Aarti Pharmalabs Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 376.91 | 527.12 | 482.88 |
| Operating Expense | 280.18 | 386.50 | 355.96 |
| Net Profit | 51.22 | 88.85 | 73.52 |
| Net Profit Margin | 13.59 | 16.86 | 15.23 |
| Earning Per Share | 5.65 | 9.80 | 8.11 |
| EBIDTA | 93.39 | 130.81 | 121.77 |
| Effective Tax Rate | 13.05 | 10.55 | 13.80 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 376.91 |
| Operating Expense | 280.18 |
| Net Profit | 51.22 |
| Net Profit Margin | 13.59 |
| Earning Per Share | 5.65 |
| EBIDTA | 93.39 |
| Effective Tax Rate | 13.05 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 1,771.35 | 1,502.13 | 1,511.25 |
| Operating Expenses Annual | 1,344.81 | 1,155.97 | 1,202.91 |
| Operating Profit Annual | 441.03 | 357.17 | 309.62 |
| Interest Annual | 25.63 | 16.63 | 20.49 |
| Depreciation | 73.80 | 64.74 | 55.73 |
| Net Profit Annual | 257.35 | 200.65 | 171.73 |
| Tax Annual | 78.99 | 73.87 | 61.63 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 1,771.35 |
| Operating Expenses Annual | 1,344.81 |
| Operating Profit Annual | 441.03 |
| Interest Annual | 25.63 |
| Depreciation | 73.80 |
| Net Profit Annual | 257.35 |
| Tax Annual | 78.99 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 4 | 0.30 | 56.50 |
| Cash Flow from Operations | 340.01 | 183.69 | 215.88 |
| Cash Flow from Investing | -419.80 | -184.40 | -115.55 |
| Cash Flow from Financing | 78.63 | 4.40 | -156.53 |
| Cash Flow at the End | 2.84 | 4 | 0.30 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 4 |
| Cash Flow from Operations | 340.01 |
| Cash Flow from Investing | -419.80 |
| Cash Flow from Financing | 78.63 |
| Cash Flow at the End | 2.84 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 24.90 | 23.78 | 20.49 |
| PBIT Margin (%) | 20.43 | 19.38 | 16.80 |
| PBT Margin (%) | 19.63 | 18.21 | 15.98 |
| Net PROFIT Margin (%) | 14.53 | 13.36 | 11.36 |
| Return On Networth / Equity (%) | 14.85 | 13.11 | 12.61 |
| Return On Networth /Employed (%) | 17.33 | 16.40 | 15.56 |
| Return On Assets (%) | 12.35 | 11.35 | 10.57 |
| Total Debt / Equity (X) | 0.20 | 0.16 | 0.20 |
| Asset Turnover Ratio (%) | 0.85 | 0.85 | 0.93 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 24.90 |
| PBIT Margin (%) | 20.43 |
| PBT Margin (%) | 19.63 |
| Net PROFIT Margin (%) | 14.53 |
| Return On Networth / Equity (%) | 14.85 |
| Return On Networth /Employed (%) | 17.33 |
| Return On Assets (%) | 12.35 |
| Total Debt / Equity (X) | 0.20 |
| Asset Turnover Ratio (%) | 0.85 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 1,127.09 | 1,011.75 | 888.06 |
| Total Current Assets Annual | 1,212.80 | 1,134.06 | 966.22 |
| Non Current Assets Annual | 1,510.81 | 1,162.85 | 1,010.15 |
| Total Shareholders Funds Annual | 1,843.87 | 1,621.46 | 1,438.58 |
| Total Assets Annual | 2,723.61 | 2,296.91 | 1,976.37 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 1,127.09 |
| Total Current Assets Annual | 1,212.80 |
| Non Current Assets Annual | 1,510.81 |
| Total Shareholders Funds Annual | 1,843.87 |
| Total Assets Annual | 2,723.61 |
EPS (INR)
Expected
5.46
Reported
5.46
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
